Clinical Trials Directory

Trials / Terminated

TerminatedNCT05840250

Continuous Glucose Monitoring and Diabetes

Improving Glucose Control and Self-Management in Adults With Type 2 Diabetes From Health Disparate Groups Using Continuous Glucose Monitoring and Education Support

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
10 (actual)
Sponsor
Hackensack Meridian Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The study is a longitudinal single-arm prospective study design. Adult patients who are African American or Hispanic with type 2 diabetes mellitus will be recruited to participate in this study. The goal of the study is to determine if the use of a continuous glucose monitoring system will improve diabetes management in persons from health disparity background. The subjects will be closely monitored for the first 3 months as they utilize the continuous glucose monitor and engage in diabetes education classes. They will then be followed for an additional 3 months to determine if they are able to maintain the same glucose control as experienced for the initial 3 months.

Conditions

Interventions

TypeNameDescription
OTHERContinuous Glucose Monitoring and Education SupportParticipants will be provided with a device to monitor their blood glucose (Abbott Free Style Libre2 Flash CGM system) along with educational materials to better understand and manage their diabetes and other supporting services. Pre and post intervention surveys will be implemented. Participants will be closely monitored for 3 months and then followed up for 3 more months for a total of 6-month participation.

Timeline

Start date
2023-05-15
Primary completion
2024-09-14
Completion
2024-09-14
First posted
2023-05-03
Last updated
2025-01-10

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05840250. Inclusion in this directory is not an endorsement.